Point72 Hong Kong LTD Dexcom Inc Call Options Transaction History

Point72 Hong Kong LTD

8 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2022 Nov 14, 2022	SELL	$76.35 - $94.18 $183,240 - $226,032	-2,400 Reduced 25.26%	7,100 $572,000
Q2 2022 Aug 15, 2022	BUY	$67.99 - $132.89 $367,146 - $717,605	5,400 Added 131.71%	9,500 $708,000
Q1 2022 May 16, 2022	BUY	$94.08 - $130.2 $235,200 - $325,500	2,500 Added 156.25%	4,100 $2.1 Million
Q4 2021 Feb 14, 2022	BUY	$129.87 - $162.82 $51,948 - $65,128	400 Added 33.33%	1,600 $859,000
Q3 2021 Nov 15, 2021	SELL	$106.71 - $143.18 $426,840 - $572,720	-4,000 Reduced 76.92%	1,200 $656,000
Q2 2021 Aug 16, 2021	SELL	$80.99 - $107.93 $56,693 - $75,551	-700 Reduced 11.86%	5,200 $2.22 Million
Q1 2021 May 17, 2021	BUY	$84.79 - $104.74 $288,286 - $356,116	3,400 Added 136.0%	5,900 $2.12 Million
Q4 2020 Feb 16, 2021	BUY	$78.0 - $104.5 $195,000 - $261,250	2,500 New	2,500 $924,000

1,013

351M

5.51M

5.6M

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $29.5B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

Get notified when there are updates to the investment portfolio of Point72 Hong Kong LTD, based on Form 13F filings with the SEC.

Stay updated on Point72 Hong Kong LTD with notifications on news.